TREATMENTS OF HEREDITARY ANGIOEDEMA

The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. La présente invention concerne d...

Full description

Saved in:
Bibliographic Details
Main Authors YEA, Christopher Martyn, SMITH, Michael David, MARSH, Sally Louise, FEENER, Edward Paul, MAETZEL, Andreas
Format Patent
LanguageEnglish
French
Published 18.08.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to treatments of hereditary angioedema (HAE). In particular, the present invention provides on-demand treatments of hereditary angioedema (HAE) by orally administering a plasma kallikrein inhibitor to a patient in need thereof on-demand. La présente invention concerne des traitements de l'angio-oedème héréditaire (AOH). En particulier, la présente invention concerne des traitements à la demande de l'angio-oedème héréditaire (AOH) par administration orale d'un inhibiteur de kallicréine plasmatique à un patient le nécessitant à la demande.
Bibliography:Application Number: WO2022GB50350